Company / Net Income
KIORA PHARMACEUTICALS INC Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$3.6M
FY2025
5-year range
-$12.5M / $3.6M
FY2021-FY2025
Trend
+128.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income returned to growth in FY2025 after 2 years of decline, reaching $4M.
Based on SEC 10-K filings.
$4M in FY2025.
Improved from -$8M to $4M over the past 4 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 128.7% year-over-year.
- Lowest net income in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.6M | +128.7% |
| FY2024 | -$12.5M | -54.6% |
| FY2021 | -$8.1M | -14.0% |
| FY2020 | -$7.1M | +34.4% |
| FY2019 | -$10.8M | +18.2% |
| FY2018 | -$13.2M | +0.9% |
| FY2017 | -$13.3M | -59.1% |
| FY2016 | -$8.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026